NP / PA
Lisbon, Tenesha
Lisbon, Tenesha was paid $767K by Medicaid between Jul 2018 and Dec 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoLISBON, TENESHA
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1356779458assigned 10/29/2013
33bProvider typePrimary Care Nurse Practitioner
28Total paid$767K
24GClaims17,763
24DCodes billed31
24AFirst – last monthJul 2018 – Dec 2024
Compared with peers
Next to other Primary Care Nurse Practitioner providers in Rhode Island
Rank by total paid#1 of 8
Median peer was paid$5K
This provider vs. median163×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 930 | $39K | |
| 2019 | 655 | $26K | |
| 2020 | 3,914 | $137K | |
| 2021 | 3,178 | $117K | |
| 2022 | 3,531 | $149K | |
| 2023 | 3,244 | $169K | |
| 2024incomplete | 2,311 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 7,261 | 6,532 | $344K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 1,251 | 1,085 | $91K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 1,018 | 992 | $83K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 1,277 | 1,187 | $77K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 7.7% | 1,043 | 992 | $59K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.5% | 1,267 | 1,226 | $19K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.0% | 251 | 244 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.9% | 1,858 | 1,785 | $15K |
| 87428 | 1.8% | 244 | 234 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 268 | 227 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 440 | 428 | $7K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | <1% | 49 | 40 | $7K |
19 more codes
| 90461 | <1% | 229 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 25 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 189 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 73 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 195 | $2K |
| 0012A | <1% | 55 | $2K | |
| 90473 | <1% | 164 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 62 | $1K |
| 99051 | <1% | 44 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 13 | $908.06 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 94 | $905.13 |
| 0011A | <1% | 38 | $845.22 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 81 | $489.86 |
| 81025 | <1% | 58 | $272.90 | |
| 99442 | <1% | 13 | $181.35 | |
| 82962 | <1% | 80 | $127.14 | |
| 81002 | <1% | 29 | $57.64 | |
| 90674 | <1% | 57 | $2.70 | |
| 90686 | <1% | 37 | $1.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.